IP Verse

Aav Vectors For Retinal And Cns Gene Therapy

Patent No. EP3137497 (titled "Aav Vectors For Retinal And Cns Gene Therapy") was filed by Genzyme on May 2, 2015. The application was issued on Mar 5, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
EUROPEAN OPPOSITIONSJan 7, 2022LEE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3137497

GENZYME
Application Number
EP15723386A
Filing Date
May 2, 2015
Status
Patent Maintained As Amended
Jan 31, 2025
Publication Date
Mar 5, 2025
External Links
Slate, Register , Google Patents